Stock MYNDF MYND LIFE SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News MYND Life Sciences Inc. OTC Markets

Equities

MYNDF

CA62857B1094

Market Closed - OTC Markets
Other stock markets
 16:29:31 05/07/2024 BST 		5-day change 1st Jan Change
0.0125 USD 0.00% Intraday chart for MYND Life Sciences Inc. 0.00% -59.94%
07-03 MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 CI
03-21 MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024
CI
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024
CI
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023
CI
MYND Life Sciences Inc. Appoints Laurie Bakke as an Independent Non-Executive Director
CI
MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.
NE
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. to Executive Chairman from the Role of CEO
CI
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. from the Role of CEO to Executive Chairman
CI
MYND Life Sciences Inc. Appoints Mr. John Campbell as Chief Executive Officer
CI
MYND Life Sciences Inc. Appoints John Campbell as President
CI
MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer
NE
Dr. Lyle Oberg Appointment as Board Chair of Alberta Health Services and Executive Chair of MYND Life Sciences
NE
MYND Life Sciences Inc. Announces Non-Binding LOI to enable merger with Cava Healthcare Inc.
NE
MYND Life Sciences Inc. entered into a non-binding letter of intent to acquire Cava Healthcare Inc.
CI
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
CI
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
CI
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023
CI
MYND Life Sciences Inc. Auditor Raises 'Going Concern' Doubt
CI
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2022
CI
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022
CI
VMYND Lifesciencs Inc. cancelled the acquisition of Tidal Psychedelics.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MYND Stock
  4. MYNDF Stock
  5. News MYND Life Sciences Inc.